Mehmandoust Mohammad, Tiris Gizem, Pourhakkak Pouran, Erk Nevin, Soylak Mustafa, Kanberoglu Gulsah S, Zahmakiran Mehmet
Department of Life Sciences and Chemistry, Constructor University, 28719, Bremen, Germany.
Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560, Ankara, Turkey.
Mikrochim Acta. 2023 Mar 18;190(4):142. doi: 10.1007/s00604-023-05722-1.
The present study aims to develop an electroanalytical method to determine one of the most significant antineoplastic agents, topotecan (TPT), using a novel and selective molecular imprinted polymer (MIP) method for the first time. The MIP was synthesized using the electropolymerization method using TPT as a template molecule and pyrrole (Pyr) as the functional monomer on a metal-organic framework decorated with chitosan-stabilized gold nanoparticles (Au-CH@MOF-5). The materials' morphological and physical characteristics were characterized using various physical techniques. The analytical characteristics of the obtained sensors were examined by cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and differential pulse voltammetry (DPV). After all characterizations and optimizing the experimental conditions, MIP-Au-CH@MOF-5 and NIP-Au-CH@MOF-5 were evaluated on the glassy carbon electrode (GCE). MIP-Au-CH@MOF-5/GCE indicated a wide linear response of 0.4-70.0 nM and a low detection limit (LOD) of 0.298 nM. The developed sensor also showed excellent recovery in human plasma and nasal samples with recoveries of 94.41-106.16 % and 95.1-107.0 %, respectively, confirming its potential for future on-site monitoring of TPT in real samples. This methodology offers a different approach to electroanalytical procedures using MIP methods. Moreover, the high sensitivity and selectivity of the developed sensor were illustrated by the ability to recognize TPT over potentially interfering agents. Hence, it can be speculated that the fabricated MIP-Au-CH@MOF-5/GCE may be utilized in a multitude of areas, including public health and food quality.
本研究旨在首次开发一种电分析方法,使用新型选择性分子印迹聚合物(MIP)方法测定最重要的抗肿瘤药物之一拓扑替康(TPT)。以TPT为模板分子,吡咯(Pyr)为功能单体,在壳聚糖稳定的金纳米粒子(Au-CH@MOF-5)修饰的金属有机框架上采用电聚合方法合成了MIP。使用各种物理技术对材料的形态和物理特性进行了表征。通过循环伏安法(CV)、电化学阻抗谱(EIS)和差分脉冲伏安法(DPV)对所得传感器的分析特性进行了研究。在完成所有表征并优化实验条件后,在玻碳电极(GCE)上对MIP-Au-CH@MOF-5和NIP-Au-CH@MOF-5进行了评估。MIP-Au-CH@MOF-5/GCE显示出0.4 - 70.0 nM的宽线性响应和0.298 nM的低检测限(LOD)。所开发的传感器在人血浆和鼻腔样本中也显示出优异的回收率,分别为94.41 - 106.16%和95.1 - 107.0%,证实了其在实际样品中对TPT进行未来现场监测的潜力。该方法为使用MIP方法的电分析程序提供了一种不同的途径。此外,所开发传感器的高灵敏度和选择性通过其识别TPT优于潜在干扰剂的能力得到了说明。因此,可以推测所制备的MIP-Au-CH@MOF-5/GCE可用于包括公共卫生和食品质量在内的众多领域。